Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

Press releases published on November 19, 2026

Fusion Fuel to Evaluate Investment Opportunities in Venezuela’s Energy and Natural Resources Sectors
Actinogen pivotal Alzheimer’s disease trial demonstrates clinical benefit in older patients with mild to moderate disease, favorable safety profile and trends towards benefit in the overall population
INTC Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Intel Corporation Class Action Reminder
Clearmind Medicine Expands PTSD Patent Portfolio with Hong Kong Patent Application Publication
Streamex Corp. and Monetary Metals & Co. Expand Partnership to Unlock Gold Yield in IRAs
Lands' End Announces Third Quarter Fiscal 2026 Earnings Conference Call
SAIC Appoints Jeffrey Little to Lead its Army and Navy Business
Captiva Verde Brings Its Clean Water Mission for Communities and the Military to a National Audience with Red Apple Media
Polara Ranks No.139 on the 2026 Deloitte  Technology Fast 500™
Polara se classe au 139e rang du palmarès Deloitte Technology Fast 500™
Medicus Pharma Regains Compliance with Nasdaq Minimum Equity Requirement for Continued Listing
Hydrofarm Names Eric Ceresnie Chief Executive Officer, Positioning Company for Its Next Phase of Growth
Plug Symposium Makes the Case for Hydrogen as a Path to Energy Security and Independence
Palvella Therapeutics Announces QTORIN™ Docetaxel, a New QTORIN™ Program for the Treatment of Extramammary Paget’s Disease (EMPD)
GCL Announces Notice of Extraordinary General Meeting on December 1, 2026
Autozi Launches Acquisition of Zhongka Supply Chain, a Well-Known Brand with RMB700 Million in Annual Revenue and More Than 3,000 Customers; Closing Expected by Month-End
Microchip Expands RT PolarFire® FPGA Portfolio with New Spaceflight Qualifications
Smartkem, Inc. announces reverse split of common stock to support continued Nasdaq listing
Evaxion announces strategy and business update and third quarter 2026 financial results
Adagene Announces First Patient Dosed in Phase 1 Study of ADG138, a Novel HER2xCD3 Double-Masked Bispecific T-Cell Engager

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Tech Times of New York

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.